Regulus Therapeutics Inc. (RGLS) Social Stream
REGULUS THERAPEUTICS INC (RGLS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RGLS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 3 | $2 | $1 | $1.666 | $1.32 | 26.21% |
| 2022-03-14 | 2 | $2 | $2 | $2 | $1.32 | 51.52% |
| 2022-06-22 | 2 | $2.001 | $2 | $2 | $1.32 | 51.52% |
| 2022-11-02 | 3 | $20.01 | $20 | $20.005 | $1.32 | 1415.53% |
| 2022-11-08 | 3 | $20.01 | $9 | $16.336 | $1.32 | 1137.58% |
| 2023-04-21 | 3 | $20.01 | $9 | $12.67 | $1.32 | 859.85% |
| 2023-09-21 | 2 | $9 | $9 | $9 | $1.32 | 581.82% |
The Trend in the Analyst Price Target
Over the past 19 months, RGLS's average price target has gone up $8.5.
Over the past 153 days, RGLS's average upside potential has been 637.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-21 | 2 | 9.00 | 9 | 9.00 | 1.35 | 566.67% |
| 2023-04-21 | 3 | 20.01 | 9 | 12.67 | 1.35 | 838.52% |
| 2023-06-28 | 2 | 9.00 | 9 | 9.00 | 1.39 | 547.48% |
| 2023-08-09 | 2 | 9.00 | 9 | 9.00 | 1.31 | 587.02% |
| 2023-09-21 | 2 | 12.00 | 9 | 10.50 | 1.29 | 713.95% |
RGLS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 15 months, RGLS's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how REGULUS THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 43.67% of that group.
- RGLS has a greater average analyst price target than 108.14% of all US stocks.
- RGLS has a lower variance in analysts' estimates than -169.1% of all US stocks.
- In terms of how REGULUS THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 655.05% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REGULUS THERAPEUTICS INC are ATOS, NHWK, and TNXP.
View All Top Stocks by Price Target
What is the outlook for RGLS? Use POWR Ratings for clearer insight into price direction.